Diana Karpman
1 – 50 of 126
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Red blood cell-derived arginase release in hemolytic uremic syndrome
(
- Contribution to journal › Article
- 2023
-
Mark
Factor B Mutation in Monozygotic Twins Discordant for Atypical Hemolytic Uremic Syndrome
(
- Contribution to journal › Article
-
Mark
Genetic investigation of Nordic patients with complement-mediated kidney diseases
(
- Contribution to journal › Article
-
Mark
Complement dysregulation associated with a genetic variant in factor H-related protein 5 in atypical hemolytic uremic syndrome
(
- Contribution to journal › Article
-
Mark
Arginase release in hemolytic uremic syndrome affects the vasculature
2023) 11th VTEC International Symposium on Shiga Toxin (Verocytotoxin) Producing Escherichia coli Infections(
- Contribution to conference › Abstract
- 2022
-
Mark
A role for complement blockade in kidney transplantation
(
- Contribution to journal › Article
-
Mark
A link between Krüppel-like factor 4, complement activation, and kidney damage
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
IgG Binds Escherichia coli Serine Protease EspP and Protects Mice From E. coli O157:H7 Infection
(
- Contribution to journal › Article
-
Mark
Apyrase decreases phage induction and Shiga toxin release from E. coli O157:H7 and has a protective effect during infection
(
- Contribution to journal › Article
-
Mark
Crosstalk between the renin–angiotensin, complement and kallikrein–kinin systems in inflammation
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Isolation and Characterization of Shiga Toxin-Associated Microvesicles
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Extracellular vesicles in renal inflammatory and infectious diseases
(
- Contribution to journal › Scientific review
-
Mark
Annexin induces cellular uptake of extracellular vesicles and delays disease in Escherichia coli O157:H7 infection
(
- Contribution to journal › Article
-
Mark
Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis
(
- Contribution to journal › Article
- 2020
-
Mark
Shiga Toxin Uptake and Sequestration in Extracellular Vesicles Is Mediated by Its B-Subunit
(
- Contribution to journal › Article
-
Mark
Shiga Toxin-Bearing Microvesicles Exert a Cytotoxic Effect on Recipient Cells Only When the Cells Express the Toxin Receptor
(
- Contribution to journal › Article
- 2019
-
Mark
Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases
(
- Contribution to journal › Scientific review
-
Mark
Kongenital trombotisk trombocytopen purpura - Ett fall med atypisk bild upptäckt i vuxen ålder
(
- Contribution to journal › Article
-
Mark
Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation
(
- Contribution to journal › Article
-
Mark
Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonism
(
- Contribution to journal › Article
- 2018
-
Mark
Aliskiren inhibits renin-mediated complement activation
(
- Contribution to journal › Article
-
Mark
Upptäckt av reninsubstrat kan leda till ny behandling för njursjukdom
(
- Contribution to journal › Debate/Note/Editorial
- 2017
-
Mark
Orphan drug policies and use in pediatric nephrology
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Haemolytic uraemic syndrome
(
- Contribution to journal › Scientific review
-
Mark
Microvesicle transfer of kinin B1-receptors is a novel inflammatory mechanism in vasculitis
(
- Contribution to journal › Article
-
Mark
Extracellular vesicles in renal disease
(
- Contribution to journal › Scientific review
-
Mark
Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney
(
- Contribution to journal › Scientific review
-
Mark
Microvesicle involvement in Shiga toxin-associated infection
(
- Contribution to journal › Scientific review
-
Mark
C1-inhibitor decreases the release of vasculitis-like chemotactic endothelial microvesicles
(
- Contribution to journal › Article
- 2016
-
Mark
An international consensus approach to the management of atypical hemolytic uremic syndrome in children
(
- Contribution to journal › Scientific review
-
Mark
Early terminal complement blockade and C6 deficiency are protective in enterohemorrhagic Escherichia coli-infected mice
(
- Contribution to journal › Article
-
Mark
Complement contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome
(
- Contribution to journal › Debate/Note/Editorial
- 2015
-
Mark
A Novel Mechanism of Bacterial Toxin Transfer within Host Blood Cell-Derived Microvesicles.
(
- Contribution to journal › Article
-
Mark
Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
NT-rådets ställningstagande till eculizumab är oacceptabelt
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Slutreplik, Diana Karpman och medförfattare : - NT-rådet bör omedelbart återkalla sitt beslut om eculizumab
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions.
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2014
-
Mark
Eculizumab treatment for rescue of renal function in IgA nephropathy.
(
- Contribution to journal › Article
-
Mark
An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome
(
- Contribution to journal › Article
-
Mark
Enterohemorrhagic Escherichia coli Pathogenesis and the Host Response
(
- Contribution to journal › Article
-
Mark
23 läkare om omskärelse av små pojkar : Läkarförbundet bör inta en mer odmjuk hållning
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The Combined Role of Galactose-Deficient IgA1 and Streptococcal IgA-Binding M Protein in Inducing IL-6 and C3 Secretion from Human Mesangial Cells: Implications for IgA Nephropathy.
(
- Contribution to journal › Article
- 2013
-
Mark
Complement activation in thrombotic microangiopathy.
(
- Contribution to journal › Scientific review
-
Mark
Ouabain Protects against Shiga Toxin-Triggered Apoptosis by Reversing the Imbalance between Bax and Bcl-xL
(
- Contribution to journal › Article
-
Mark
Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab
(
- Contribution to journal › Article
-
Mark
Complement Activation Associated with ADAMTS13 Deficiency in Human and Murine Thrombotic Microangiopathy.
(
- Contribution to journal › Article
-
Mark
Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions.
(
- Contribution to journal › Article
-
Mark
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
(
- Contribution to journal › Article
- 2012
-
Mark
The Antimicrobial Peptide Cathelicidin Protects Mice from Escherichia coli O157:H7-Mediated Disease.
(
- Contribution to journal › Article
-
Mark
Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed
(
- Contribution to journal › Debate/Note/Editorial